← All trials
NCT04847960
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 22, 2021
- Primary completion
- Jul 31, 2021
- Completion date
- Oct 31, 2021
- First posted
- Apr 19, 2021
- Last posted
- Apr 19, 2021
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Trisakti UniversityLead sponsor
- University of IndonesiaStudy chair
- University of IndonesiaCollaborator
- BioGaia ABCollaborator
- Duke UniversityStudy director
- Duke UniversityCollaborator
- Trisakti UniversityReponsible party - principal investigator
- Trisakti UniversityOverall official - principal investigator
- Trisakti UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.